Checks and Balances on FDA's Authority

Holly Fernandez Lynch; Peter Lurie; I Glenn Cohen

doi:10.1001/jama.2024.11987

Checks and Balances on FDA's Authority

JAMA. 2024 Sep 3;332(9):705-706. doi: 10.1001/jama.2024.11987.

Authors

Holly Fernandez Lynch¹, Peter Lurie², I Glenn Cohen³

Affiliations

¹ Perelman School of Medicine and Carey Law School, University of Pennsylvania, Philadelphia.
² Center for Science in the Public Interest, Washington, DC.
³ Harvard Law School, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Cambridge, Massachusetts.

PMID: 38889181
DOI: 10.1001/jama.2024.11987

No abstract available

Plain language summary

In this Viewpoint, the authors refute recent suggestions that the US Food and Drug Administration (FDA) is not accountable for its decisions, pointing out the legal, legislative, and executive checks and balances on the agency.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Abortifacient Agents, Steroidal
Advisory Committees
Drug Approval / legislation & jurisprudence
Humans
Mifepristone
Supreme Court Decisions
United States
United States Food and Drug Administration* / legislation & jurisprudence
United States Food and Drug Administration* / organization & administration

Substances

Mifepristone
Abortifacient Agents, Steroidal